CD4 T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy

Journal:

Nature Medicine

Published:

2026-01-15

DOI:

10.1038/s41591-025-04121-8

Affiliations:

14

Authors:

56

Go to article

Institutions	Authors	Share
University of Pennsylvania (Penn), United States of America (USA)	45.600000 45.600000 45.600000 45.600000 45.600000	0.81
Abramson Cancer Center, Penn, United States of America (USA)	9.700000	0.17
Children's Hospital of Philadelphia (CHOP), United States of America (USA)	0.500000	0.01
Parker Institute for Cancer Immunotherapy, United States of America (USA)	0.200000	0.00

Interested in Oncology and Carcinogenesis?